News - Janssen-Cilag

Filter

Current filters:

Janssen-Cilag

Popular Filters

Gilead and Johnson & Johnson get EU backing for HIV drugs Eviplera and Edurant, respectively

29-11-2011

In the first of two pieces of good news for HIV/AIDS drug developers, US biotech firm Gilead Sciences…

Anti-viralsEdurantEuropeEvipleraGilead SciencesJanssen-CilagJohnson & JohnsonPharmaceuticalRegulationTibotec

EU approval for Janssen-Cilag’s Zytiga in prostate cancer and Novartis’ Votubia for SEGA

08-09-2011

Belgium-based Janssen-Cilag International, a subsidiary of US health care giant Johnson & Johnson (NYSE:…

AfinitorEuropeJanssen-CilagJohnson & JohnsonNovartisOncologyPharmaceuticalRegulationVotubiaZytiga

Johnson & Johnson unit recalls batches of “smelly” AIDS drug Prezista

12-05-2011

Janssen-Cilag International, a subsidiary of US health care giant Johnson & Johnson (NYSE: JNJ), which…

Anti-viralsJanssen-CilagJohnson & JohnsonPharmaceuticalPrezistaRegulation

Back to top